BRIgHT: Resilience Intervention for Older, HIV-Infected Women

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03071887
Collaborator
National Center for Complementary and Integrative Health (NCCIH) (NIH)
13
2
1
9
6.5
0.7

Study Details

Study Description

Brief Summary

The goal of this study is to refine and pilot the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and living with chronic disease. The investigators will adapt the 3RP resiliency intervention to the needs of this population and conduct preliminary testing of the group intervention via an open pilot study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Relaxation Response Resiliency Program (3RP)
N/A

Detailed Description

Overview.

Participants will be women living with HIV (N=up to 40) age 50 or over. Women will be recruited from the Boston area. Based on the investigators' qualitative work, the investigators will deliver an adapted version of the 3RP resiliency intervention to groups of 5-8 HIV-infected women age 50 and over. The 3RP intervention will consist of 8-10 weekly sessions of 90 minutes each focused on skills training to build and enhance resilience. The investigators will conduct baseline and post-treatment quantitative assessments, in addition to individual exit interviews to solicit feedback on the intervention. These data will be used to inform the design of a future randomized pilot study.

Study procedures.

Participants (N = up to 40) will be HIV-infected women age 50 or over . Participants will be recruited via study flyers (posted in the infectious disease clinics at local hospitals and in the waiting areas of Boston area community organizations) and provider referral. Once an individual expresses interest in the study, a research assistant will screen that individual to assess study eligibility criteria. Individuals who meet inclusion criteria will be invited to sign informed consent and complete an in-person baseline assessment. Participants will then complete the intervention (described below), a post-treatment assessment, and an individual in-depth exit interview to provide feedback on their experience in the study.

3RP Intervention:

Once enrolled in the study, participants will complete weekly group sessions of the 3RP intervention. Sessions will focus on developing an understanding of stress sources and physiology, and on developing a regular practice of eliciting the relaxation response (RR) and learning cognitive behavioral and positive psychology skills to enhance resiliency to long-term stress. Participants will be encouraged to practice skills (RR practice, thoughts records to learn adaptive thinking) between group sessions.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This is an open pilot of the adapted Relaxation Response Resiliency Program (3RP).This is an open pilot of the adapted Relaxation Response Resiliency Program (3RP).
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Developing a Resilience Intervention for Older, HIV-Infected Women
Actual Study Start Date :
Nov 27, 2017
Actual Primary Completion Date :
Aug 27, 2018
Actual Study Completion Date :
Aug 27, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Treatment arm - Relaxation Response Resiliency Program (3RP) (this is an open pilot; the treatment arm is the only arm)

Behavioral: Relaxation Response Resiliency Program (3RP)
The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators plan to adapt the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.

Outcome Measures

Primary Outcome Measures

  1. Number of Participants Completing Treatment Sessions [Approximately 10 weeks after baseline]

    The investigators will assess feasibility by collecting data on the number of completed treatment sessions.

  2. Participant Satisfaction With Study Procedures [Approximately 10 weeks after baseline]

    Acceptability will be assessed using scores on the Client Satisfaction Questionnaire (CSQ-8). Response options as follows, "Very satisfied", "Mostly satisfied", "Indifferent or mildly dissatisfied", and "Quite dissatisfied".

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • biologically born women who endorse a female identity

  • HIV-infected

  • age 50 or older

  • English speaking

Exclusion Criteria:
  • presence of an active (i.e. untreated) and interfering psychiatric disorder (e.g., bipolar disorder, schizophrenia, substance abuse)

  • have participated in a structured cognitive behavioral therapy and/or a mind-body intervention in the past year

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114
2 Boston Medical Center Boston Massachusetts United States 02118

Sponsors and Collaborators

  • Massachusetts General Hospital
  • National Center for Complementary and Integrative Health (NCCIH)

Investigators

  • Principal Investigator: Christina Psaros, PhD, Massachusetts General Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Christina Psaros, Assistant Professor of Psychology, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT03071887
Other Study ID Numbers:
  • 2017P000404
  • R34AT009170
First Posted:
Mar 7, 2017
Last Update Posted:
Oct 28, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

Participant Flow

Recruitment Details The three open pilot groups and qualitative exit interviews were conducted between December 2017 and July 2018 through community outreach, flyers, and referrals from healthcare providers at the Infectious Disease units of two Boston-area hospitals.
Pre-assignment Detail
Arm/Group Title Treatment: Relaxation Response Resiliency Program (3RP)
Arm/Group Description The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators adapted the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.
Period Title: Overall Study
STARTED 13
COMPLETED 7
NOT COMPLETED 6

Baseline Characteristics

Arm/Group Title Treatment: Relaxation Response Resiliency Program (3RP)
Arm/Group Description The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators adapted the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.
Overall Participants 13
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
57.6
(5.2)
Sex: Female, Male (Count of Participants)
Female
13
100%
Male
0
0%
Race/Ethnicity, Customized (Count of Participants)
Black/African American
8
61.5%
White
4
30.8%
Other
1
7.7%
Education (Count of Participants)
Less than high school degree
5
38.5%
High school graduate/GED
1
7.7%
College/graduate school partial/degree
7
53.8%
Current Employment Status (Count of Participants)
Full-Time
1
7.7%
Part-Time
2
15.4%
Disabled/retired
9
69.2%
Other
1
7.7%
Relationship Status (Count of Participants)
Single
5
38.5%
Married/Partnered
3
23.1%
Separated/Divorced
5
38.5%
Monthly Income (Count of Participants)
$10,000 or less
9
69.2%
More than $10,000
4
30.8%
Years since diagnosis (Count of Participants)
More than 5 years ago
12
92.3%
Less than 5 years ago
1
7.7%

Outcome Measures

1. Primary Outcome
Title Number of Participants Completing Treatment Sessions
Description The investigators will assess feasibility by collecting data on the number of completed treatment sessions.
Time Frame Approximately 10 weeks after baseline

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment: Relaxation Response Resiliency Program (3RP)
Arm/Group Description The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators adapted the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.
Measure Participants 13
Attended at least half of group sessions
4
30.8%
Attended fewer than half of group sessions
9
69.2%
2. Primary Outcome
Title Participant Satisfaction With Study Procedures
Description Acceptability will be assessed using scores on the Client Satisfaction Questionnaire (CSQ-8). Response options as follows, "Very satisfied", "Mostly satisfied", "Indifferent or mildly dissatisfied", and "Quite dissatisfied".
Time Frame Approximately 10 weeks after baseline

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment: Relaxation Response Resiliency Program (3RP)
Arm/Group Description The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators adapted the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.
Measure Participants 7
Very satisfied
6
46.2%
Mostly satisfied
1
7.7%

Adverse Events

Time Frame Adverse event data were collected over the 8 months study enrollment and participation (December 2017 through August 2018).
Adverse Event Reporting Description
Arm/Group Title Treatment: Relaxation Response Resiliency Program (3RP)
Arm/Group Description The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The 3RP intervention currently consists of eight, 90-minute weekly group sessions. The investigators adapted the intervention to address common concerns for older, HIV-infected women, including: stress of managing a chronic long-term, life threatening illness; additional medical comorbidities; pain and fatigue; stigma and social isolation; depression and anxiety; and sexuality concerns.
All Cause Mortality
Treatment: Relaxation Response Resiliency Program (3RP)
Affected / at Risk (%) # Events
Total 0/13 (0%)
Serious Adverse Events
Treatment: Relaxation Response Resiliency Program (3RP)
Affected / at Risk (%) # Events
Total 0/13 (0%)
Other (Not Including Serious) Adverse Events
Treatment: Relaxation Response Resiliency Program (3RP)
Affected / at Risk (%) # Events
Total 0/13 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Christina Psaros
Organization Massachusetts General Hospital
Phone 617.726.7458
Email cpsaros@mgh.harvard.edu
Responsible Party:
Christina Psaros, Assistant Professor of Psychology, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT03071887
Other Study ID Numbers:
  • 2017P000404
  • R34AT009170
First Posted:
Mar 7, 2017
Last Update Posted:
Oct 28, 2019
Last Verified:
Oct 1, 2019